The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Combined Modality High-Dose Chemotherapy Followed by Adoptive Immunotherapy to Eliminate Minimal Residual Disease in Metastatic Breast Cancer.
 
Miho Sakumura
No Relationships to Disclose
 
Takayuki Ando
No Relationships to Disclose
 
Ayumu Hosokawa
Honoraria - Chugai Pharma; Eisai; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst)
 
Hiroshi Mihara
No Relationships to Disclose
 
Hiroaki Takagi
No Relationships to Disclose
 
Hiroki Yoshita
No Relationships to Disclose
 
Sohachi Nanjo
No Relationships to Disclose
 
Akira Ueda
No Relationships to Disclose
 
Haruka Fujinami
No Relationships to Disclose
 
Shinya Kajiura
No Relationships to Disclose
 
Kohei Ogawa
No Relationships to Disclose
 
Toshiro Sugiyama
No Relationships to Disclose